Armstrong Advisory Group, Inc Outlook Therapeutics, Inc. Transaction History
Armstrong Advisory Group, Inc
- $1.08 Billion
- Q1 2024
A detailed history of Armstrong Advisory Group, Inc transactions in Outlook Therapeutics, Inc. stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 3,580 shares of OTLK stock, worth $26,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,580
Previous 3,580
-0.0%
Holding current value
$26,420
Previous $1,000
4100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OTLK
# of Institutions
7Shares Held
67.1KCall Options Held
0Put Options Held
0-
Prospera Financial Services Inc30.5KShares$225,0900.0% of portfolio
-
Endurance Wealth Management, Inc.20KShares$147,6000.0% of portfolio
-
Urban Wealth Management, LLC7.47KShares$55,1500.03% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$29,5200.0% of portfolio
-
Harbour Investments, Inc. Madison, WI1.3KShares$9,5940.0% of portfolio
About Outlook Therapeutics, Inc.
- Ticker OTLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 226,144,992
- Market Cap $1.67B
- Description
- Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...